Host Jeremy C. Park talks with Dr. Jolieke van Oosterwijk, Chief Scientific Officer with US Biologic, who highlights the Memphis-based company developing groundbreaking orally delivered vaccines, changing global disease prevention and allowing safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans. During the interview, Jolieke discusses how they are developing a breakthrough means to increase the number of people taking their vaccines – an edible vaccine in “gummy” form; so, it can be eaten and not taken as a normal shot via needle. This vaccine is “thermostable,” which means it doesn’t have to be stored in a refrigerator, so it could potentially be mailed to homes, increase everyone’s access to lifesaving flu vaccines. The vaccine is based on a platform, so it can be used for a wide variety of vaccines (e.g., flu vaccines or Covid vaccines) for both humans and animals (e.g., avian flu vaccines). Jolieke also shares how they are collaborating and partnering with other organizations, including the Biomedical Advanced Research and Development Authority (BARDA), which is one of the U.S.’s leading government entities for pandemic response.
Visit www.usbiologic.com to learn more.